Euphemia Leung

5.7k total citations
160 papers, 4.3k citations indexed

About

Euphemia Leung is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Euphemia Leung has authored 160 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 37 papers in Oncology and 37 papers in Immunology. Recurrent topics in Euphemia Leung's work include Cell Adhesion Molecules Research (27 papers), Protein Kinase Regulation and GTPase Signaling (13 papers) and Immunotherapy and Immune Responses (13 papers). Euphemia Leung is often cited by papers focused on Cell Adhesion Molecules Research (27 papers), Protein Kinase Regulation and GTPase Signaling (13 papers) and Immunotherapy and Immune Responses (13 papers). Euphemia Leung collaborates with scholars based in New Zealand, United Kingdom and United States. Euphemia Leung's co-authors include Bruce C. Baguley, Graeme J. Finlay, Geoffrey W. Krissansen, Marjan Askarian-Amiri, David Barker, Jagat R. Kanwar, Jóhannes Reynisson, Norbert Wagner, Werner Müller and Klaus Lehnert and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Euphemia Leung

154 papers receiving 4.2k citations

Peers

Countries citing papers authored by Euphemia Leung

Since Specialization

Citations

This map shows the geographic impact of Euphemia Leung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Euphemia Leung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Euphemia Leung more than expected).

Fields of papers citing papers by Euphemia Leung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Euphemia Leung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Euphemia Leung. The network helps show where Euphemia Leung may publish in the future.

Co-authorship network of co-authors of Euphemia Leung

This figure shows the co-authorship network connecting the top 25 collaborators of Euphemia Leung. A scholar is included among the top collaborators of Euphemia Leung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Euphemia Leung. Euphemia Leung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NUPR1 contributes to endocrine therapy resistance by modulating BIRC5 expression and inducing luminal B-ERBB2⁺ subtype-like characteristics in estrogen receptor-positive breast cancer cells 2025 ·Journal of Cancer ·(unknown), Yi-Chen Lin, Yung-Chieh Chang, (unknown), (unknown), Ta‐Kang Yeh, Euphemia Leung, (unknown), Shang‐Hung Chen, Chun Hei Antonio Cheung	1
2	Design, synthesis, and SAR of antiproliferative activity of trioxatriangulene derivatives 2025 ·RSC Medicinal Chemistry ·(unknown), (unknown), Matthew P. Sullivan, Chatchakorn Eurtivong, Euphemia Leung, Lisa I. Pilkington, David Barker	0
3	Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency Disorders 2024 ·Clinical Immunology ·Rohan Ameratunga, Hilary Longhurst, Euphemia Leung, Richard Steele, Klaus Lehnert, (unknown)	1
4	Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells 2024 ·Journal of Liposome Research ·(unknown), Andrew N. Shelling, (unknown), David Porter, Euphemia Leung, Zimei Wu	4
5	Stability of trastuzumab during nanomedicine formulation using SEC-HPLC coupled with polyacrylamide gel electrophoresis 2023 ·Pharmaceutical Development and Technology ·(unknown), Andrew N. Shelling, David Porter, Euphemia Leung, Zimei Wu	4
6	Synthesis and Anti-Proliferative Evaluation of Arctigenin Analogues with C-9′ Derivatisation 2023 ·International Journal of Molecular Sciences ·(unknown), Euphemia Leung, Lisa I. Pilkington, David Barker	0
7	Functionalisation of extracellular vesicles with cyclic-RGDyC potentially for glioblastoma targeted intracellular drug delivery 2023 ·Biomaterials Advances ·(unknown), Euphemia Leung, Lawrence W. Chamley, Zimei Wu	23
8	Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection 2022 ·PubMed ·Rohan Ameratunga, Klaus Lehnert, Euphemia Leung, Davide Comoletti, Russell G. Snell, (unknown), William G.H. Abbott, (unknown), Richard Steele, Jeff J. McKee, Andrew C. Muscroft‐Taylor, Shanthi Ameratunga, Natalie J. Medlicott, Shyamal C. Das, (unknown), Miguel E. Quiñones‐Mateu, Helen Petousis‐Harris, A. M. Jordan	10
9	Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs 2021 ·Oncology and Therapy ·Euphemia Leung, (unknown), Jennifer A. Hollywood, Ayesha Zafar, Petr Tomek, David Barker, Lisa I. Pilkington, (unknown), Ries J. Langley, Nuala A. Helsby, C.J. Squire, Bruce C. Baguley, William A. Denny, Jóhannes Reynisson, Ivanhoe K. H. Leung	14
10	YM155 and BIRC5 downregulation induce genomic instability via autophagy-mediated ROS production and inhibition in DNA repair 2021 ·Pharmacological Research ·Siao Muk Cheng, Tzu‐Yu Lin, Yung-Chieh Chang, (unknown), Euphemia Leung, Chun Hei Antonio Cheung	17
11	Dual or multiple drug loaded nanoparticles to target breast cancer stem cells 2020 ·RSC Advances ·(unknown), (unknown), Euphemia Leung, Darren Svirskis, Andrew N. Shelling, Zimei Wu	38
12	Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activity 2019 ·Chemical Communications ·Shahida Parveen, Muhammad Hanif, Euphemia Leung, Kelvin K. H. Tong, Annie Yang, Jonathan W. Astin, Gayan Heruka De Zoysa, Tasha R. Steel, (unknown), Sanam Movassaghi, Tilo Söhnel, Vijayalekshmi Sarojini, Stephen M. F. Jamieson, Christian G. Hartinger	48
13	BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells 2019 ·Autophagy ·Tzu‐Yu Lin, (unknown), Shang‐Hung Chen, Sailu Sarvagalla, Pai‐Sheng Chen, Mohane Selvaraj Coumar, Siao Muk Cheng, Yung-Chieh Chang, (unknown), Euphemia Leung, Chun Hei Antonio Cheung	96
14	Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells 2016 ·Frontiers in Pharmacology ·(unknown), (unknown), (unknown), Siao Muk Cheng, Shang‐Hung Chen, (unknown), (unknown), (unknown), Chien‐Feng Li, Jagat R. Kanwar, Euphemia Leung, (unknown), (unknown), Wei‐Jan Huang, Yi‐Ching Wang, Chun Hei Antonio Cheung	53
15	ZFAS1: a long noncoding RNA associated with ribosomes in breast cancer cells 2016 ·Biology Direct ·(unknown), Euphemia Leung, Bruce C. Baguley, Graeme J. Finlay, David Cameron‐Smith, Vandré C. Figueiredo, Marjan Askarian-Amiri	63
16	Relationships between Signaling Pathway Usage and Sensitivity to a Pathway Inhibitor: Examination of Trametinib Responses in Cultured Breast Cancer Lines 2014 ·PLoS ONE ·Euphemia Leung, Ji Eun Kim, Marjan Askarian-Amiri, Gordon W. Rewcastle, Graeme J. Finlay, Bruce C. Baguley	24
17	Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival 2014 ·Frontiers in Oncology ·(unknown), Jack U. Flanagan, Taryn N. Green, Euphemia Leung, Marjan Askarian-Amiri, Wayne R. Joseph, (unknown), Richard Isaacs, James H. Shaw, (unknown), Matthew J. During, Graeme J. Finlay, Bruce C. Baguley, Maggie L. Kalev‐Zylinska	22
18	Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells 2011 ·Cancer Biology & Therapy ·Euphemia Leung, Ji Eun Kim, Gordon W. Rewcastle, Graeme J. Finlay, Bruce C. Baguley	64
19	β7 integrins contribute to demyelinating disease of the central nervous system 2000 ·Journal of Neuroimmunology ·Jagat R. Kanwar, (unknown), (unknown), Euphemia Leung, Werner Müller, Norbert Wagner, Geoffrey W. Krissansen	73
20	Effect of granulocyte-macrophage colony-stimulating factor and interleukin 3 on the v-src oncogene. Inhibition of tyrosine kinase activity in the absence of changes in gene expression. 1988 ·The Journal of Immunology ·(unknown), D.R. Jenkins, (unknown), Euphemia Leung	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact